F-35 TR-3 software upgrades stalled in testing, delaying new combat capability and raising cybersecurity concerns.
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2026 Earnings Call Transcript March 12, 2026 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.06086 EPS, expectations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results